HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yuan Shao Selected Research
Yuan Shao Research Topics
Disease
40
Neoplasms (Cancer)
08/2022 - 06/2007
11
Prostatic Neoplasms (Prostate Cancer)
08/2022 - 01/2013
7
Carcinogenesis
08/2022 - 05/2013
7
Carcinoma (Carcinomatosis)
05/2022 - 09/2014
6
Squamous Cell Carcinoma of Head and Neck
01/2022 - 11/2011
6
Inflammation (Inflammations)
12/2021 - 01/2009
5
Thyroid Neoplasms (Thyroid Cancer)
03/2022 - 04/2017
5
Stroke (Strokes)
01/2021 - 06/2013
4
Adenoma (Adenomas)
11/2021 - 05/2004
4
Neoplasm Metastasis (Metastasis)
01/2021 - 08/2012
4
Body Weight (Weight, Body)
01/2020 - 08/2007
4
Cystitis
02/2019 - 03/2012
4
Ischemic Stroke
07/2018 - 06/2013
3
Thrombocytopenia (Thrombopenia)
07/2022 - 12/2013
3
Neonatal Alloimmune Thrombocytopenia
11/2021 - 12/2013
3
Hypertension (High Blood Pressure)
11/2021 - 05/2004
3
Urinary Bladder Neoplasms (Bladder Cancer)
06/2021 - 12/2009
3
Hemorrhage
03/2021 - 12/2013
3
Platelet Glycoprotein IV Deficiency
07/2020 - 12/2013
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2016 - 11/2014
2
Nasopharyngeal Carcinoma
07/2022 - 10/2021
2
Lung Neoplasms (Lung Cancer)
06/2022 - 09/2015
2
Respiratory Tract Diseases (Respiratory Tract Disease)
01/2022 - 12/2019
2
Papillary Thyroid Cancer
01/2021 - 01/2019
2
Hypoxia (Hypoxemia)
01/2020 - 01/2009
2
Interstitial Cystitis (Interstitial Cystitis, Chronic)
02/2019 - 03/2010
2
Pain (Aches)
10/2015 - 03/2010
2
Stomach Neoplasms (Stomach Cancer)
01/2014 - 01/2014
2
Hepatocellular Carcinoma (Hepatoma)
01/2014 - 01/2013
2
Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
12/2012 - 01/2011
1
Meningioma (Meningiomas)
07/2022
1
Hydrops Fetalis (Fetal Edema)
07/2022
1
Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
01/2022
1
Allergic Rhinitis
12/2021
1
Fetal Death
11/2021
1
Fibrosis (Cirrhosis)
11/2021
1
Herpes Zoster
11/2021
Drug/Important Bio-Agent (IBA)
10
Proteins (Proteins, Gene)
FDA Link
08/2022 - 06/2007
6
Long Noncoding RNA
IBA
01/2022 - 01/2019
6
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2014
4
Catenins
IBA
07/2022 - 03/2018
4
Cytokines
IBA
11/2021 - 03/2011
4
MicroRNAs (MicroRNA)
IBA
11/2017 - 05/2013
3
Antibodies
IBA
07/2022 - 12/2013
3
Biological Products
IBA
01/2022 - 05/2013
3
Messenger RNA (mRNA)
IBA
01/2022 - 02/2014
3
Aldosterone
IBA
11/2021 - 05/2004
3
Antigens
IBA
01/2021 - 01/2014
3
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
02/2019 - 06/2013
3
Interleukin-6 (Interleukin 6)
IBA
01/2019 - 06/2013
3
Enzymes
IBA
06/2013 - 06/2007
3
Hyaluronic Acid (Hyaluronan)
IBA
06/2013 - 03/2010
3
Heparin (Liquaemin)
FDA Link
Generic
06/2013 - 06/2007
2
RNA (Ribonucleic Acid)
IBA
08/2022 - 10/2016
2
taconite
IBA
01/2022 - 12/2019
2
Silicon Dioxide (Silica)
FDA Link
Generic
01/2022 - 01/2020
2
Small Interfering RNA (siRNA)
IBA
12/2021 - 01/2013
2
Collagen
IBA
11/2021 - 01/2017
2
Pharmaceutical Preparations
IBA
04/2021 - 01/2013
2
Kallikreins (Kallikrein)
IBA
01/2021 - 01/2009
2
DNA (Deoxyribonucleic Acid)
IBA
10/2020 - 07/2020
2
Monoclonal Antibodies
IBA
07/2020 - 08/2012
2
Androgens
IBA
01/2020 - 03/2018
2
Oxygen (Dioxygen)
IBA
01/2020 - 03/2012
2
Neurokinin-1 Receptors (Neurokinin 1 Receptor)
IBA
02/2019 - 06/2017
2
Antineoplastic Agents (Antineoplastics)
IBA
04/2017 - 01/2015
2
Transcription Factors (Transcription Factor)
IBA
04/2017 - 01/2016
2
Ligands
IBA
01/2017 - 06/2007
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2016 - 06/2013
2
Protamines (Protamine Sulfate)
FDA Link
10/2016 - 06/2013
2
Lipopolysaccharides
IBA
10/2016 - 06/2013
2
Dinoprostone (PGE2)
FDA Link
10/2016 - 01/2009
2
Indicators and Reagents (Reagents)
IBA
10/2016 - 02/2014
2
Phosphotransferases (Kinase)
IBA
09/2015 - 12/2009
2
Resveratrol
IBA
06/2015 - 11/2014
2
Radiation-Sensitizing Agents
IBA
06/2015 - 11/2014
2
Cadherins (E-Cadherin)
IBA
01/2015 - 01/2013
2
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
02/2014 - 06/2007
2
Cytochrome P-450 CYP2C19
IBA
02/2014 - 06/2013
2
Aurora Kinase A
IBA
01/2013 - 01/2013
1
N-methyladenosine
IBA
08/2022
1
6-methyladenine
IBA
08/2022
1
Volatile Organic Compounds
IBA
06/2022
1
Carbon
IBA
06/2022
1
Protein Kinases (Protein Kinase)
IBA
03/2022
1
Allergens
IBA
01/2022
1
Cytoplasmic and Nuclear Receptors (Nuclear Receptors)
IBA
01/2022
1
Leukemia Inhibitory Factor
IBA
12/2021
1
Antagomirs
IBA
12/2021
1
Intravenous Immunoglobulins (IVIG)
FDA Link
11/2021
1
Immune Checkpoint Inhibitors
IBA
11/2021
Therapy/Procedure
8
Therapeutics
01/2022 - 01/2009
4
Radiotherapy
03/2018 - 03/2012
3
Nephroureterectomy
05/2022 - 07/2017
3
Lasers (Laser)
01/2021 - 06/2007
3
Drug Therapy (Chemotherapy)
03/2018 - 12/2009
2
Sutures (Suture)
03/2021 - 12/2020
2
Conservative Treatment
04/2016 - 03/2014
2
Intravesical Administration
06/2013 - 03/2010
2
Adrenalectomy
05/2012 - 03/2010